N/A
N=52
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery
Osteoarthritis
Bottom Line
View on ClinicalTrials.gov: NCT02638623 ↗Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Number of Participants With Postoperative Complications — 0; 1; 0; 0 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lactated Ringer (Drug); Placebo (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- West Virginia University
- Primary completion
- Oct 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Postoperative Complications |
0; 1; 0; 0; 0; 0 | — |
| SECONDARY 90 Day Readmission Count |
0; 1; 20; 18 | — |
| SECONDARY Duration of Hospital Stay (Hours) |
53.86; 36.13 | — |
| SECONDARY Duration of Surgery |
122.68; 126.3 | — |
| SECONDARY Emesis Episodes |
0.26; 0.11 | — |
| SECONDARY Volume of Fluid Administred |
1635; 1518 | — |
Summary
The investigators are testing the hypothesis that administering 2L of body temperature warmed lactated ringer's intravenously prior to surgery can optimize the postoperative and recovery of patients undergoing total hip and total knee arthroplasty.
Eligibility Criteria
Inclusion Criteria
- All patients >= 18 years of age, undergoing a total primary knee or hip arthroplasty
Exclusion Criteria
- Patients weighing less than 80 kg.
- Patients undergoing irrigation and debridement, explantation, or revision will not be eligible.
- history of kidney disease, congestive heart failure, pulmonary edema, cirrhosis of the liver, or history of systemic fluid overloard will be excluded from the study.
- No one will be excluded based on gender, ethnicity or race.
Data sourced from ClinicalTrials.gov (NCT02638623). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.